Category: AtheroMed Inc.Syndicate content

AtheroMed wins 510(k) clearance for atherectomy catheter

January 29, 2014 by Chris Walker

AtheroMed lands 510(k) clearance from the FDA for its Phoenix atherectomy system, used for treating peripheral artery disease.

AtheroMed wins 510(k) clearance for atherectomy catheter

AtheroMed secured 510(k) clearance from the FDA for its Phoenix device, an atherectomy catheter used for treating peripheral artery disease.

The low-profile catheter aims to minimizes vessel interaction and designed to be easy to set up. The Phoenix system features front-cutting technology that cuts while clearing away clearing debris with an internal Archimedes screw, which runs the length of the catheter. The device is available in a variety of sizes, according to a press release.

AtheroMed closes in on $4.5M for PAD treatment

December 13, 2013 by Chris Walker

California-based AtheroMed is just shy of raising $4.5 million through an offering of debt, options, warrants and other securities.

AtheroMed seeks around $5M

AtheroMed is closing in on a $4.5 million fundraising round, offering debt and options offering, SEC documents show.

The Menlo Park, Calif.-based medical device company has so far raised $4.3 million for its operations, according to a regulatory filing.

Stealthy AtheroMed raises $6M for peripheral atherectomy device

April 4, 2013 by Brad Perriello

AtheroMed, which is developing an atherectomy device to treat peripheral artery disease, reports a $6 million funding round.

AtheroMed

AtheroMed said it's raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings.

The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.

AtheroMed is still flying under the radar, to judge by the 1-page website, which provides only an email link to contact the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp